The Federal Trade Commission (FTC or Commission) authorized action on November 6 to block the proposed merger of two hospitals located in Huntington, West Virginia. The FTC issued an administrative complaint alleging that the transaction would create a near monopoly for general acute care inpatient hospital …
FTC Gives Mixed Review of South Carolina’s Nurse Supervision Proposal
November 3, 2015 Leave a Comment
The Federal Trade Commission (FTC or Commission) submitted written comments on November 2nd to South Carolina’s state legislature on the competitive impact of proposals to modify the supervision requirements for advanced practice registered nurses (APRNs) in the state. While the FTC approved of a state bill that …
Court Rejects Claim that a Doctor’s Loss of Privileges is an Antitrust Injury
August 27, 2015 Leave a Comment
A federal appeals court held that a doctor who lost his privileges at a local hospital failed to establish an antitrust injury sufficient to confer standing under the Sherman Act. The United States Court of Appeals for the Third Circuit affirmed a district court ruling that Dr. Victor Novak could not show that he …
OMG: Kim Kardashian Prompts FDA Warning Letter
August 11, 2015 Leave a Comment
Kim Kardashian recently trumpeted the beneficial effects of Diclegis, a pill indicated for the treatment of nausea and vomiting of pregnancy for certain women, to her over 42 million Instagram followers. One such Kardashian devotee apparently works at the U.S. Food and Drug Administration (FDA), which sent a …
Minnesota Joins 9-State Compact Expediting Telemedicine Across State Lines
June 30, 2015 Leave a Comment
Effective July 1, 2015, Minnesota will join the Interstate Medical Licensure Compact, a group attempting to expedite the licensing of physicians seeking to provide telemedicine services to patients located in other states. Minnesota joins eight other states in the Compact – Alabama, Idaho, Montana, Nevada, South …
Your Drug Patent Rights Transfer May Be Reportable, Court of Appeals Confirms
June 12, 2015 Leave a Comment
On Nov. 6, 2013, the Federal Trade Commission (FTC or Commission) modified its Hart-Scott-Rodino Act (HSR) rules to clarify that transfers of patent rights within the pharmaceutical industry constitute potentially reportable asset transactions even if patent holders retain limited manufacturing rights or …